Journal articleAuthors : King, Elizabeth A. (2023)
Targeted protein degradation using heterobifunctional Proteolysis-Targeting Chimeras (PROTACs) or molecular
glues has arisen as a powerful therapeutic modality for degrading disease targets. While PROTAC design is
becoming more modular and straightforward, the discovery of novel molecular glue degraders has been more
challenging. While several recent studies have showcased phenotypic screening and counter-screening
approaches to discover new molecular glue degraders, me...